ArticleAntimicrobial agents and chemotherapy2023

Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases.

Frédéric Cawez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.